Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
Open Access
- 1 June 2011
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 52 (6), 1181-1187
- https://doi.org/10.1194/jlr.m012526
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular OutcomesArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians’ Health StudyClinical Chemistry, 2004
- Lp(a) Particles Mold Fibrin-Binding Properties of Apo(a) in Size-Dependent MannerArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Apolipoprotein(a) isoforms and coronary heart disease in men: A nested case-control studyAtherosclerosis, 1997
- The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.JCI Insight, 1994
- cDNA sequence of human apolipoprotein(a) is homologous to plasminogenNature, 1987
- Protein composition of Lp(a) lipoprotein from human plasmaFEBS Letters, 1983
- The framingham offspring study. Design and preliminary dataPreventive Medicine, 1975